Andreas Schneeweiß
- Oncology top 0.05%
- Cancer Research top 0.05%
- Molecular Biology top 1%
- Pulmonary and Respiratory Medicine top 0.2%
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Co-authors
- Javier CortésChristof SohnHans‐Peter SinnKlaus PantelFrederik MarméJosé BaselgaEva CiruelosSung‐Bae Kim
- Topics
- Breast Cancer Treatment Studies (218 papers)Cancer Treatment and Pharmacology (197 papers)HER2/EGFR in Cancer Research (170 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Andreas Schneeweiß
578 papers receiving 18.8k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Oncology 13.3k
- Cancer Research 8.3k
- Molecular Biology 4.6k
- Pulmonary and Respiratory Medicine 4.4k
- Radiology, Nuclear Medicine and Imaging 2.3k
Countries citing papers authored by Andreas Schneeweiß
This map shows the geographic impact of Andreas Schneeweiß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Schneeweiß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Schneeweiß more than expected).
Fields of papers citing papers by Andreas Schneeweiß
This network shows the impact of papers produced by Andreas Schneeweiß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Schneeweiß. The network helps show where Andreas Schneeweiß may publish in the future.
Co-authorship network of co-authors of Andreas Schneeweiß
This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Schneeweiß. A scholar is included among the top collaborators of Andreas Schneeweiß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Schneeweiß. Andreas Schneeweiß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 7 | |
| 5 | 9 | |
| 6 | 19 | |
| 7 | 7 | |
| 8 | 17 | |
| 9 | 2 | |
| 10 | 26 | |
| 11 | 27 | |
| 12 | 35 | |
| 13 | First-line Bevacizumab-containing Therapy for HER2-negative Metastatic Breast Cancer: Final Results from a Prospective German Study. | 10 |
| 14 | 35 | |
| 15 | 30 | |
| 16 | 298 | |
| 17 | 214 | |
| 18 | 126 | |
| 19 | 29 | |
| 20 | 47 |
About Andreas Schneeweiß
Andreas Schneeweiß is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 608 papers that have together received 19.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (218 papers), Cancer Treatment and Pharmacology (197 papers) and HER2/EGFR in Cancer Research (170 papers). The work is most often cited by research in Cancer Research (8.3k citations), Oncology (13.3k citations) and Pulmonary and Respiratory Medicine (4.4k citations). Andreas Schneeweiß has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Javier Cortés, Christof Sohn, Hans‐Peter Sinn, Klaus Pantel, Frederik Marmé, José Baselga, Eva Ciruelos, Sung‐Bae Kim, Graham Ross and Sandra M. Swain. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.